
Cheelcare Announces Upsizing of Non-Brokered Private Placement to $3.0 Million
Cheelcare Announces Upsizing of Non-Brokered Private Placement to $3.0 Million

Cheelcare Announces Upsizing of Non-Brokered Private Placement to $3.0 Million
Comprehensive Healthcare Systems Engages E.F. Hutton to lead Potential U.S. Exchange Uplisting
ZYUS Life Sciences Corporation Announces Closing of Third Tranche of Secured Loan Financing
LIR Life Sciences Completes Comparative Animal Study Showing Successful Protamine-Enhanced Permeation Transport of Both Semaglutide and Tirzepatide
Knight Therapeutics Announces Repayment of Revolving Credit Facility
Hemostemix' $1,000,000 Private Placement and Update
Sernova Biotherapeutics Receives FDA Orphan Drug Designation for Autologous Islet Transplantation for Prevention of Diabetes Due to Total Pancreatectomy
Avricore Health Closes $1.254 Million Financing
Onco-Innovations Completes Project with Kuano, Using Their Quantum-Based Platform to Deliver Insights for PNKP Inhibitor Technology Optimization
DIAGNOS Submits Modified and Updated Health Canada Licence Application for CARA System Platform
16 Million People, One Underserved Disease: The AI Imaging Push to Close the Congenital Heart Gap
APOTEX HEALTH CORP. ANNOUNCES CLOSING OF UPSIZED INITIAL PUBLIC OFFERING AND EXERCISE OF OVER-ALLOTMENT OPTION IN FULL
Vitalist Announces Strategic Partnership with Health-e Insights to Expand Vitalist's Remote Patient Monitoring Services
Rocket Doctor AI Subsidiary Treatment.com Secures Year 2 NIH Funding to Advance AI-Powered Family Health History Tool
VitalHub Announces Deployments of Referral Management Solutions